Could this vaccine stop the superbug gonorrhea?

NCT ID NCT05630859

Completed ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental gonorrhea vaccine in healthy adults aged 18 to 50. The goal was to see if the vaccine is safe and can prevent gonorrhea infections. Over 1,000 participants received either the vaccine or a placebo (salt water shot) and were monitored for side effects and infection rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sexually transmitted disease gonorrhea prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEXUALLY TRANSMITTED DISEASES

Contacts and locations

Locations

GSK Investigational Site

Washington D.C., District of Columbia, 20009, United States
GSK Investigational Site

Lenexa, Kansas, 66219, United States
GSK Investigational Site

Boston, Massachusetts, 02215, United States
GSK Investigational Site

Springfield, Missouri, 65802, United States
GSK Investigational Site

The Bronx, New York, 10467, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 48202, United States
GSK Investigational Site

Austin, Texas, 78705, United States
GSK Investigational Site

Salvador, 41680-020, Brazil
GSK Investigational Site

Lyon, 69004, France
GSK Investigational Site

Paris, 75475, France
GSK Investigational Site

Pierre-Bénite, 69495, France
GSK Investigational Site

Bochum, 44787, Germany
GSK Investigational Site

Frankfurt, 60596, Germany
GSK Investigational Site

Hamburg, 20146, Germany
GSK Investigational Site

Manila, 1000, Philippines
GSK Investigational Site

Johannesburg, 2001, South Africa
GSK Investigational Site

Soweto, 2013, South Africa
GSK Investigational Site

Barcelona, 08015, Spain
GSK Investigational Site

Madrid, 28006, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Valencia, 46026, Spain
GSK Investigational Site

London, SW10 9NH, United Kingdom
GSK Investigational Site

London, WC1E 6JB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.